Position in ABT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$53,491
+$36,577 QoQ
Shares Held
521
+285.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Anfield Capital Management, LLC holds $234,451 across 10 Medical Devices names. ABT ranks #2 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
1,600 | $100,480 | |
| 2 | ABT |
Abbott Laboratories
This page
|
521 | $53,491 | |
| 3 | SYK |
Stryker Corp
|
86 | $28,258 | |
| 4 | STE |
STERIS plc
|
91 | $20,122 | |
| 5 | PHG |
Koninklijke Philips NV
|
431 | $11,809 | |
| 6 | BSX |
Boston Scientific Corp
|
167 | $10,479 | |
| 7 | MDT |
Medtronic plc
|
56 | $4,852 | |
| 8 | PODD |
Insulet Corp
|
20 | $4,196 |
All Filings in ABT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,491 | 521 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $16,914 | 135 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $18,081 | 135 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $31,554 | 232 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $16,979 | 128 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $14,478 | 128 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $14,593 | 128 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $13,300 | 128 | Shares | Defined | 2024-07-31 | |
| 2021-09-30 | $11,694 | 99 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $14,491 | 125 | Shares | Defined | 2021-08-03 | |
| No filing history on record for this holder in this stock. | ||||||